India's Foreign Investment and Promotion Board (FIPB) has delayed a deal by Fosun to purchase Gland Pharmaceuticals for $1.4 billion, as reported Business Standard Friday.
-
In the planned deal reached in July 2016, Fosun would obtain a 86-percent stake in Gland.
-
The agreement was the first reached after India's government relaxed foreign direct investment norms in the country.









(All Rights Reserved)